Lupin Pharmaceuticals Recalls Millions of Eye Drop Bottles Due to Contamination

Lupin Pharmaceuticals has initiated a recall of over 2.5 million bottles of prednisolone acetate ophthalmic suspension, a corticosteroid eye drop. The Class II recall, which indicates potential temporary health consequences, was prompted by the discovery of a foreign substance in the product. While the recall began in early June, it is now being widely reported, with doctors advising patients to only discontinue use if their specific prescription is on the recall list.